Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Carrie Brodmerkel, Eric Wadman, Richard G. Langley, Kim Papp, Marc Bourcier, Yves Poulin, Vincent Ho, Lyn Guenther, Rod Kunynetz, Simon Nigen,

PubMed · 2013 · 69 citations · 23 references

Abstract

Long-term treatment (≥3 years) with ustekinumab does not compromise the immune response to T-cell-dependent/-independent vaccines in patients with moderate-to-severe psoriasis.

References

23